Company Filing History:
Years Active: 2001
Title: Ronald Cohn: Innovator in Cardiomyopathy Research
Introduction
Ronald Cohn is a prominent inventor based in Iowa City, IA (US). He has made significant contributions to the field of cardiomyopathy research. His innovative work has led to the development of a unique mouse model that aids in understanding the pathogenesis of this condition.
Latest Patents
Cohn holds a patent related to the pathogenesis of cardiomyopathy. The patent discloses a mouse that is homozygous for a disrupted δ-sarcoglycan gene. This disruption prevents the synthesis of functional δ-sarcoglycan in the cells of the mouse. As a result, the mouse exhibits a reduced amount of β- and ε-sarcoglycan and sarcospan, leading to a disruption of the sarcoglycan-sarcospan complex in its smooth muscle. Additionally, the patent also describes a mouse that is homozygous for a disrupted β-sarcoglycan gene, which similarly affects the synthesis of functional β-sarcoglycan.
Career Highlights
Cohn is affiliated with the University of Iowa Research Foundation, where he continues to advance his research. His work has garnered attention for its potential implications in understanding and treating cardiomyopathy.
Collaborations
Cohn collaborates with notable colleagues, including Kevin P. Campbell and Ramon Coral. Their combined expertise enhances the research efforts in the field of cardiomyopathy.
Conclusion
Ronald Cohn's innovative contributions to cardiomyopathy research through his patented mouse models represent a significant advancement in the understanding of this condition. His work continues to inspire further research and development in the field.